Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cereblon-based heterodimerizable chimeric antigen receptors

Cereblon-based heterodimerizable chimeric antigen receptors

US Patent 11331380 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Slipper2025
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2025
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2024
Substituted aminopurine compounds, compositions thereof, and methods of treatmen2023
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2022
Treatment of cancer with TOR kinase inhibitors2021
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2021
Substituted aminopurine compounds, compositions thereof, and methods of treatmen2021
Substituted aminopurine compounds, compositions thereof, and methods of treatmen2020
Substituted aminopurine compounds, compositions thereof, and methods of treatmen2020
Methods for treating cancer using TOR kinase inhibitor combination therapy compr2018
Treatment of cancer with dihydropyrazino-pyrazines2018